INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
MR

Mehta Rajat

EVP, GBL Commercial OperationsCIK 0002081681

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score30
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
456 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    BIO-RAD LABORATORIES, INC.EVP, GBL Commercial Operations · Sep 9, 2026
30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F
$90K
233 sh
Sep 5, 2026
Sep 9, 2026
traded Sep 5, 2026
+4d
SEC FORM 4

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
1,370 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC FORM 4

Evidence

30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$195K
504 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC FORM 4

Evidence

15
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Grant or award
A—
4,601 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC FORM 4

Evidence

23
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
456 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC FORM 4

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
1,370 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC FORM 4

Evidence